Company: BSX
Filing Date: 2025-11-03
Form Type: 10-Q
Source: 0000885725-25-000050
Chunk: 79

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-11-03
Form: 10-Q
Item: Part I, Item 1
Chunk 79
---
ies256 429 686 212 449 661 Watchman470 43 512 342 38 380 Cardiac Rhythm Management354 224 578 349 213 561 Electrophysiology607 258 865 366 160 527 Cardiology1,687 954 2,641 1,269 859 2,129 Peripheral Interventions405 297 702 316 285 602 Cardiovascular2,092 1,251 3,343 1,586 1,145 2,731 Total Net Sales$3,294 $1,770 $5,065 $2,593 $1,616 $4,209 

36

Table of Contents

Nine Months Ended September 30,20252024BusinessesU.S.Int'lTotalU.S.Int'lTotalEndoscopy$1,338 $818 $2,157 $1,227 $769 $1,996 Urology1,478 514 1,992 1,098 473 1,570 Neuromodulation661 205 866 616 191 807 MedSurg3,478 1,537 5,015 2,941 1,433 4,373 Interventional Cardiology Therapies740 1,373 2,114 608 1,370 1,977 Watchman1,306 117 1,423 996 107 1,103 Cardiac Rhythm Management1,066 679 1,746 1,054 658 1,713 Electrophysiology1,706 729 2,435 795 460 1,255 Cardiology4,818 2,899 7,717 3,452 2,595 6,048 Peripheral Interventions1,183 873 2,056 924 841 1,765 Cardiovascular6,002 3,772 9,773 4,377 3,436 7,813 Total Net Sales$9,479 $5,309 $14,788 $7,317 $4,869 $12,186 Refer to Note J – Segment Reporting for information on our reportable segments.Three Months Ended September 30,Nine Months Ended September